Literature DB >> 15120670

Irinotecan-induced interstitial pneumonia.

O Michielin1, E Udry, D Périard, O Matzinger, J A Lobrinus, R Stupp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15120670     DOI： 10.1016/S1470-2045(04)01471-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  An autopsy case of acute pulmonary toxicity related to irinotecan.

Authors:  Ana Ruiz-Casado; Victor Castellano; Fernando Moreno
Journal:  Clin Transl Oncol       Date:  2008-09       Impact factor: 3.405

2.  Phase-I dose finding and pharmacokinetic study of the novel hydrophilic camptothecin ST-1968 (namitecan) in patients with solid tumors.

Authors:  M Joerger; D Hess; A Delmonte; E Gallerani; P Barbieri; S Pace; C Sessa
Journal:  Invest New Drugs       Date:  2015-02-20       Impact factor: 3.850

Review 3.  Anticancer therapy and lung injury: molecular mechanisms.

Authors:  Li Li; Henry Mok; Pavan Jhaveri; Mark D Bonnen; Andrew G Sikora; N Tony Eissa; Ritsuko U Komaki; Yohannes T Ghebre
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-23       Impact factor: 4.512

4.  A Case of Organizing Pneumonia Associated with FOLFIRI Chemotherapy.

Authors:  Yoon Jeong Lee; Jun-Hyun Kim; Sun Woong Kim; Won Chan Kang; Soo Jung Kim; Ji Hye Kim; Sun Jong Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-12-31

5.  A Rare Case of Irinotecan-induced Interstitial Pulmonary Disease and Diffuse Alveolar Hemorrhage in a Patient with Pancreatic Cancer.

Authors:  Lingbin Meng; Bo Deng; Baoqiong Liu; Umair Majeed; Wen Wang
Journal:  Cureus       Date:  2019-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.